Omeros Corporation

OMER

$17.84

Name : Omeros Corporation

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,291,407,616.00

EPSttm : 1.22

Omeros Corporation

$17.84

1.71%

$0.31

OMER — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

18.52

Margin Of Safety %

Put/Call OI Ratio

0.55

EPS Next Q Diff

0.04

EPS Last/This Y

0.74

EPS This/Next Y

0.54

Price

18.14

Target Price

36.67

Analyst Recom

1.5

Performance Q

4.61

Upside

177.7%

Beta

Ticker: OMER

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	OMER	18.89	0.59	0.90	61520
2026-10-14	OMER	18.41	0.60	0.15	62612
2026-10-15	OMER	18.79	0.60	0.39	62335
2026-10-16	OMER	16.19	0.58	0.67	65169
2026-10-19	OMER	16.35	0.60	0.35	57340
2026-10-20	OMER	16.54	0.60	0.94	58227
2026-10-21	OMER	16.24	0.60	0.34	58175
2026-10-22	OMER	16.87	0.60	0.32	58485
2026-10-23	OMER	16.55	0.59	0.64	59326
2026-10-26	OMER	16.31	0.59	0.25	59828
2026-10-27	OMER	17.49	0.59	0.02	59500
2026-10-28	OMER	17.88	0.57	1.53	60840
2026-10-29	OMER	18.86	0.57	0.32	61083
2026-10-30	OMER	18.46	0.56	0.53	61812
2026-11-02	OMER	17.82	0.55	0.21	62380
2026-11-03	OMER	18.29	0.56	2.50	62278
2026-11-04	OMER	18.2	0.56	0.05	62295
2026-11-05	OMER	17.15	0.56	0.21	62411
2026-11-06	OMER	16.92	0.56	0.14	62801
2026-11-09	OMER	17.47	0.55	0.21	63329
2026-11-10	OMER	17.28	0.55	0.12	63637
2026-11-11	OMER	18.15	0.55	0.09	63722
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	OMER	18.89	93.8	-	0.69
2026-10-14	OMER	18.43	93.8	-	0.69
2026-10-15	OMER	18.80	93.8	-	0.69
2026-10-16	OMER	16.17	93.8	-	0.69
2026-10-19	OMER	16.35	93.8	-	0.69
2026-10-20	OMER	16.35	93.8	-	0.69
2026-10-21	OMER	16.54	93.8	-	0.69
2026-10-22	OMER	16.87	93.8	-	0.69
2026-10-23	OMER	16.56	93.8	-	0.69
2026-10-26	OMER	16.30	93.8	-	0.69
2026-10-27	OMER	17.50	93.8	-	0.69
2026-10-28	OMER	17.89	93.8	-	0.69
2026-10-29	OMER	18.94	93.8	-	0.69
2026-10-30	OMER	18.45	93.8	-	0.69
2026-11-02	OMER	17.82	93.8	-	0.69
2026-11-03	OMER	18.27	93.8	-	0.69
2026-11-04	OMER	18.19	93.8	-	0.69
2026-11-05	OMER	17.06	93.8	-	0.69
2026-11-06	OMER	16.91	93.8	-	0.69
2026-11-09	OMER	17.57	93.8	-	0.69
2026-11-10	OMER	17.30	93.8	-	0.69
2026-11-11	OMER	18.14	93.8	-	0.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	OMER	-3.82	8.69	16.43
2026-10-14	OMER	-3.82	8.69	16.43
2026-10-15	OMER	-3.82	8.69	16.43
2026-10-16	OMER	-3.82	8.69	16.43
2026-10-19	OMER	-3.82	8.75	16.43
2026-10-20	OMER	-3.82	8.75	16.43
2026-10-21	OMER	-3.82	8.75	16.43
2026-10-22	OMER	-3.82	8.75	16.43
2026-10-23	OMER	-3.82	8.75	16.43
2026-10-26	OMER	-3.82	8.59	16.43
2026-10-27	OMER	-3.82	8.59	16.50
2026-10-28	OMER	-3.82	8.59	16.50
2026-10-29	OMER	-3.82	8.59	16.50
2026-10-30	OMER	-3.82	8.59	16.50
2026-11-02	OMER	-3.82	8.54	16.50
2026-11-03	OMER	-3.82	8.54	16.50
2026-11-05	OMER	-3.82	8.54	16.50
2026-11-06	OMER	-3.82	8.54	16.50
2026-11-09	OMER	-3.82	8.50	16.50
2026-11-10	OMER	-3.82	8.50	16.50
2026-11-11	OMER	-3.82	8.50	18.52
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.02

Avg. EPS Est. Current Quarter

-0.02

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

-3.82

Institutional Transactions

8.5

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

14.6

Max Drawdown 5-Year %

-87

Target Price

36.67

P/E

12.62

Forward P/E

17.17

PEG

P/S

34.2

P/B

P/Free Cash Flow

EPS

1.44

Average EPS Est. Cur. Y

0.69

EPS Next Y. (Est.)

1.23

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

324.88

Relative Volume

0.47

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ OMER Healthcare

$18.15

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

17/25

Volume

11/15

Valuation

10/20

TP/AR

2/10

Options

6/10

RSI

52.5

Range 1M

49.6%

Sup Dist

6.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

25/30

Estimates

0/20

Inst/Vol

7/15

Options

9/10

EPS Yr

1750%

EPS NY

28.2%

52W%

78.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +127.1% upside

Quality

11/30

Valuation

16/30

Growth

18/25

Stability

5/10

LT Trend

3/5

Upside

+127.1%

Quality

OMER — P/E HistoricalBiotechnology

Omeros Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 175

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.

OMER

Latest News

—

Caricamento notizie per OMER…

stock quote shares OMER – Omeros Corporation Stock Price stock today

news today OMER – Omeros Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch OMER – Omeros Corporation yahoo finance google finance

stock history OMER – Omeros Corporation invest stock market

stock prices OMER premarket after hours

ticker OMER fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: OMER

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y